Lantheus HoldingsLNTH -1.78%82 Days Inventory is 39.27 as of Mar. 2026, which is 14% below its 10-year median of 45.66. GuruFocus rates LNTH with a GF Score™ of 82/100 and a GF Value™ of $90.85 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 918 Drug Manufacturers companies, Lantheus Holdings ranks better than 96.62% on this metric.
The historical rank and industry rank for Lantheus Holdings's Days Inventory or its related term are showing as below:
LNTH'
s Days Inventory Range Over the Past 10 Years
Min: 30.94 Med: 45.66 Max: 65.79
Current: 38.15
During the past 13 years, Lantheus Holdings's highest Days Inventory was 65.79. The lowest was 30.94. And the median was 45.66.
LNTH's Days Inventory is ranked better than 96.62% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs LNTH: 38.15
Lantheus Holdings's Days Inventory
declined
from Mar. 2025 (46.33) to Mar. 2026 (39.27).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lantheus Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lantheus Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.17.
Lantheus Holdings (NAS:LNTH) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Lantheus Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lantheus Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Lantheus Holdings Days Inventory Related Terms
Lantheus Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Lantheus Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LNTH vs LQDA, HIMS, AMRX: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lantheus Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Lantheus Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lantheus Holdings (LNTH) has a Days Inventory of 39.27 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lantheus Holdings and its competitors. This is 14% below median its historical median of 45.66. Over the past decade, Lantheus Holdings' Days Inventory has ranged from 30.94 to 65.79. According to the industry distribution chart, Lantheus Holdings ranks #31 out of 918 companies in the Drug Manufacturers industry, placing it in the top 3.4%.
Is Lantheus Holdings' Days Inventory too high?
Lantheus Holdings' current Days Inventory of 39.27 is 14% below median its 10-year median of 45.66. Over the past 10 years, this metric has ranged from a low of 30.94 to a high of 65.79. The Drug Manufacturers industry median Days Inventory is 164.43. Lantheus Holdings' value of 39.27 is 76.1% below this industry median. Based on the distribution chart, Lantheus Holdings ranks #31 out of 918 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Lantheus Holdings has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lantheus Holdings' Days Inventory compare to LQDA and HIMS?
According to the Drug Manufacturers industry distribution chart, Lantheus Holdings ranks #31 out of 918 companies for Days Inventory. This places Lantheus Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.43. Lantheus Holdings' value of 39.27 is 76.1% below this benchmark. Historically, Lantheus Holdings' own Days Inventory has ranged from 30.94 to 65.79 over the past decade. While the company's 10-year median is 45.66 vs. the industry median of 164.43, Lantheus Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lantheus Holdings's current Days Inventory of 39.27 is 76.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lantheus Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lantheus Holdings's current Days Inventory is 39.27, which is 14% below median its own 10-year median of 45.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lantheus Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lantheus Holdings (LNTH) is currently considered Modestly Overvalued. The stock's GF Value™ is $90.85, compared to a current price of $108.93 — trading 19.9% above its estimated fair value. The current Days Inventory is 39.27, which is 14% below median its 10-year median of 45.66 and 76.1% below the Drug Manufacturers industry median of 164.43. Lantheus Holdings' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lantheus Holdings (LNTH), the current Days Inventory is 39.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lantheus Holdings (LNTH) Overvalued in 2026?
Based on GuruFocus' analysis, Lantheus Holdings stock appears to be overvalued.
The current stock price of $108.93 is trading 19.9% above its estimated GF Value™ of $90.85.
GuruFocus considers Lantheus Holdings to be Modestly Overvalued.
Key valuation signals for LNTH:
Days Inventory: 39.27 (14% below median its 10-year median of 45.66)
GF Value™: $90.85 vs. price of $108.93 (19.9% above fair value)
Industry Position: 76.1% below the Drug Manufacturers median (#31 of 918)
No single metric tells the full story. See the LNTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
82GF Score
Get the complete analysis for LNTH
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LNTH has been successfully added to your 
